Biogen Inc.

(BIIB)

By |

Profile

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders.

Contact Information

Website: www.biogenidec.com
Email: IR@biogen.com
Main Phone: +1 617 679-2000
Address: 225 Binney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
Employees: 7350
NAICS: Biological Produ
$ 290.02 $ -1.11 (-0.38%)
Last Price 290.02 Change $ -1.11 Change % -0.38 Tick N/A
Bid 289.74 Bid Size 100.00 Ask 290.03 Ask Size 100.00
Open 290.13 High 291.42 Low 289.01 Prev Close 291.13
Last Trade Volume 134,454 52 Wk Hi 333.65 52 Wk Low 223.02
Market Cap 62.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 215,951,945.00 EPS (TTM) 16.94 PE Ratio 16.80 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 19 120
Number of Buys 12 56
Number of Sells 7 64
Net Activity 9707 370386
Last 10 Buys Shares
Alexander J. Denner, 1,000
Alexander J. Denner, 1,000
Stelios Papadopoulos 1,000
Stelios Papadopoulos 1,000
Caroline D. Dorsa 1,000
Caroline D. Dorsa 1,000
Caroline D. Dorsa 1,000
Caroline D. Dorsa 1,000
Caroline D. Dorsa 1,000
Caroline D. Dorsa 1,000
Last 10 Sell Shares
George A. Scangos 1,000
Adam Koppel 1,000
George A. Scangos 1,000
George A. Scangos 1,000
George A. Scangos 1,000
George A. Scangos 1,000
George A. Scangos 1,000
George A. Scangos 1,000
Adam Koppel 1,000
George A. Scangos 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 414 414 414 414
Low Target Price Estimate 283 283 268 283
Mean Target Price Estimate 349.5 349.5 346.79 351.14
Standard Deviation 44.17 44.17 45.47 40.66
Date of Most Recent Estimate 08/12/16 08/08/16 08/01/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 9 10 9 9
Moderate Buy 1 2 2 2
Hold 5 5 5 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.7 1.68 1.72 1.79